Follow
Cristobal Morales Portillo
Cristobal Morales Portillo
Hospital Vithas Sevilla. Hospital Universitario Virgen Macarena. Seville
Verified email at vithas.es - Homepage
Title
Cited by
Cited by
Year
Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial
D Rubino, N Abrahamsson, M Davies, D Hesse, FL Greenway, C Jensen, ...
Jama 325 (14), 1414-1425, 2021
5312021
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
S Del Prato, SE Kahn, I Pavo, GJ Weerakkody, Z Yang, J Doupis, ...
The Lancet 398 (10313), 1811-1824, 2021
3352021
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised …
P Dandona, C Mathieu, M Phillip, L Hansen, SC Griffen, D Tschöpe, ...
The lancet Diabetes & endocrinology 5 (11), 864-876, 2017
3022017
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study
P Dandona, C Mathieu, M Phillip, L Hansen, D Tschöpe, F Thorén, J Xu, ...
Diabetes Care 41 (12), 2552-2559, 2018
2232018
Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis
MP Ocaranza, J Moya, V Barrientos, R Alzamora, D Hevia, C Morales, ...
Journal of hypertension 32 (4), 771-783, 2014
1162014
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled …
M von Herrath, SC Bain, B Bode, JO Clausen, K Coppieters, L Gaysina, ...
The Lancet Diabetes & Endocrinology 9 (4), 212-224, 2021
872021
Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease
Z Zhou, MJ Jardine, Q Li, BL Neuen, CP Cannon, D De Zeeuw, ...
Stroke, 2021
712021
Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: a randomized clinical trial in …
A Philis‐Tsimikas, LK Billings, R Busch, CM Portillo, R Sahay, N Halladin, ...
Diabetes, Obesity and Metabolism 21 (6), 1399-1408, 2019
632019
Practical approach to initiating SGLT2 inhibitors in type 2 diabetes
F Gomez-Peralta, C Abreu, A Lecube, D Bellido, A Soto, C Morales, ...
Diabetes Therapy 8, 953-962, 2017
622017
Incidence and care‐related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project
RJ Barranco, F Gomez‐Peralta, C Abreu, M Delgado, R Palomares, ...
Diabetic Medicine 32 (11), 1520-1526, 2015
572015
Diabetes and periodontal diseases: an established two-way relationship
CA Molina, LF Ojeda, MS Jiménez, CM Portillo, IS Olmedo, ...
Journal of Diabetes Mellitus 6 (4), 209-229, 2016
532016
Increased salivary oxidative stress parameters in patients with type 2 diabetes: relation with periodontal disease
C Arana, AM Moreno-Fernández, G Gómez-Moreno, C Morales-Portillo, ...
Endocrinología, Diabetes y Nutrición (English ed.) 64 (5), 258-264, 2017
432017
Patients’ and physicians’ preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment
C Morillas, R Feliciano, PF Catalina, C Ponte, M Botella, J Rodrigues, ...
Patient preference and adherence, 1443-1458, 2015
342015
Once-weekly efpeglenatide dose-range effects on glycemic control and body weight in patients with type 2 diabetes on metformin or drug naive, referenced to liraglutide
J Rosenstock, CH Sorli, ME Trautmann, C Morales, U Wendisch, G Dailey, ...
Diabetes Care 42 (9), 1733-1741, 2019
332019
Clinical approach to flash glucose monitoring: an expert recommendation
A Chico, E Aguilera, FJ Ampudia-Blasco, V Bellido, ...
Journal of diabetes science and technology 14 (1), 155-164, 2020
282020
Compatibility and safety of ultra rapid lispro with continuous subcutaneous insulin infusion in patients with type 1 diabetes: PRONTO-Pump Study
BW Bode, SK Garg, P Norwood, C Morales, T Hardy, R Liu, D Ignaut
Diabetes technology & therapeutics 23 (1), 41-50, 2021
272021
De la diabetes a la insuficiencia cardiaca¿ Existe la miocardiopatía diabética?
C Saldarriaga-Giraldo, V Navas, C Morales
Revista Colombiana de Cardiología 27, 12-16, 2020
152020
Anti-IL-21–Liraglutide Study Group Investigators and Contributors. Anti-interleukin-21 antibody and liraglutide for the preservation of b-cell function in adults with recent …
M von Herrath, SC Bain, B Bode, JO Clausen, K Coppieters, L Gaysina, ...
Lancet Diabetes Endocrinol 9, 212-224, 2021
142021
Eficacia de una estrategia para mejorar los indicadores de calidad del Proceso Asistencial Integrado Diabetes Mellitus 2 en el Centro Avanzado de Diabetes Macarena
JM Vélez, R García, E Pina, C Morales, C Escalera, A Ortega, B Poyatos, ...
Atención Primaria 51 (1), 18-23, 2019
132019
Effectiveness and safety of insulin glargine 300 U/ml in comparison with insulin degludec 100 U/ml evaluated with continuous glucose monitoring in adults with type 1 diabetes …
I Conget, MÁ Mangas, C Morales, J Caro, M Giménez, M Borrell, ...
Diabetes Therapy 12, 2993-3009, 2021
122021
The system can't perform the operation now. Try again later.
Articles 1–20